Company Filing History:
Years Active: 2023
Title: Dibyendu Dana: Innovator in Pharmaceutical Chemistry
Introduction
Dibyendu Dana is a notable inventor based in Elmont, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for Rho-associated coiled-coil kinase (ROCK).
Latest Patents
Dibyendu Dana holds a patent for "Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors." This invention provides compounds with specific formulas and pharmaceutically acceptable salts. The patent outlines pharmaceutical compositions and methods for treating various conditions where inhibiting ROCK1, ROCK2, or both has therapeutic benefits. He has 1 patent to his name.
Career Highlights
Dibyendu Dana is currently associated with Angion Biomedica Corporation, where he applies his expertise in pharmaceutical development. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Dibyendu has collaborated with notable colleagues, including An-Hu Li and Dong Sung Lim, contributing to advancements in their shared field of research.
Conclusion
Dibyendu Dana's work exemplifies the impact of innovation in pharmaceutical chemistry. His contributions continue to pave the way for new therapeutic approaches in medicine.